Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -69.48% | 753.37% | -110.48% | -26.51% | 163.95% |
| Total Depreciation and Amortization | 15.51% | 2.10% | -0.99% | 4.07% | 6.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.64% | -46.84% | 9.24% | 253.87% | -28.21% |
| Change in Net Operating Assets | -86.16% | -17.66% | -162.40% | 122.06% | -136.76% |
| Cash from Operations | -30.46% | 26.10% | -59.77% | 690.86% | -37.95% |
| Capital Expenditure | 20.12% | -16.63% | 4.98% | -73.68% | 28.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 900.25% | 86.67% | -10,800.90% | 136.51% | -198.04% |
| Cash from Investing | -1,732.55% | 82.99% | -3,409.12% | 38.42% | -20.51% |
| Total Debt Issued | -- | -- | 100.00% | -100.02% | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.33% | -130.63% | 210.08% | -2,751.02% | 121.30% |
| Cash from Financing | 3,058.90% | 68.03% | -5.22% | -1,012.82% | 49.13% |
| Foreign Exchange rate Adjustments | 81.11% | -820.00% | 178.13% | -104.69% | 99.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -660.58% | 143.80% | -177.38% | 587.85% | -28.12% |